PEI’s multiple protonatable amines create electrostatic attraction with negatively charged DNA or RNA. Primary, secondary, and tertiary amines provide the chemical sites for this association, allowing the polymer to condense nucleic-acid cargo and shield it. That charge-based organization supports later delivery steps in a biological delivery context.
After internalization, PEI’s protonatable groups can buffer the surrounding environment within endosomal compartments. That buffering is relevant because it can support release of associated nucleic-acid cargo from those compartments, a step connecting intracellular processing with access to the cell. The mechanism therefore complements the initial electrostatic condensation and uptake functions.
Delivery performance depends on more than the presence of PEI. Polymer size, branching, charge, and dose can each be tuned, and these variables influence the balance between delivery efficiency and cytotoxicity. Consequently, a formulation that improves nucleic-acid transfer may still require adjustment if its dose or polymer properties produce unacceptable effects on cells.
An optimization workflow begins by varying PEI formulation properties and dose rather than treating the polymer as a fixed reagent. Researchers can compare resulting delivery efficiency with observed cytotoxicity, then select conditions that provide a useful balance. This approach is important because formulation variables can affect both delivery performance and cellular tolerance.
PEI-based formulations support several gene-transfer workflows: transient gene expression, RNA delivery, and production of recombinant proteins. These uses span introducing nucleic-acid instructions into cells and enabling expression-based experiments. The method is therefore relevant when researchers need a delivery tool for expression studies or protein-production work.
Delivery efficiency alone does not establish that a PEI formulation is suitable. Researchers also need to consider cytotoxicity, because the polymer’s dose, charge, size, and branching can shift the balance between successful cargo delivery and harmful cellular effects. Evaluating both outcomes helps distinguish a productive formulation from one that performs well only at an unacceptable biological cost.